Gene · 6579
Papers2,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Preliminary clinical study of the safety of hepatectomy predicted by gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced T1 mapping magnetic resonance imaging. | JGH Open | 2021 | 33732886 | PubTator, text mining | PubMed |
| A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies. | Front Cell Dev Biol | 2021 | 33732695 | PubTator, text mining | PubMed |
| A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis. | BMC Gastroenterol | 2021 | 33726685 | PubTator, text mining | PubMed |
| Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects. | Arch Toxicol | 2021 | 33719007 | PubTator, text mining | PubMed |
| The Advantages of Indocyanine Green Fluorescence Imaging in Detecting and Treating Pediatric Hepatoblastoma: A Preliminary Experience. | Front Pediatr | 2021 | 33718305 | PubTator, text mining | PubMed |
| Enteric reabsorption processes and their impact on drug pharmacokinetics. | Sci Rep | 2021 | 33707635 | PubTator, text mining | PubMed |
| Drug-Drug Interactions at Organic Cation Transporter 1. | Front Pharmacol | 2021 | 33679412 | PubTator, text mining | PubMed |
| First genome-wide association study on rocuronium dose requirements shows association with SLCO1A2. | Br J Anaesth | 2021 | 33676726 | PubTator, text mining | PubMed |
| Successful Prediction of Human Steady-State Unbound Brain-to-Plasma Concentration Ratio of P-gp Substrates Using the Proteomics-Informed Relative Expression Factor Approach. | Clin Pharmacol Ther | 2021 | 33675056 | PubTator, text mining | PubMed |
| Permeability of the Cyanotoxin Microcystin-RR across a Caco-2 Cells Monolayer. | Toxins (Basel) | 2021 | 33673481 | PubTator, text mining | PubMed |
| Are In Vitro Human Blood-Brain-Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics? | Cancers (Basel) | 2021 | 33668807 | PubTator, text mining | PubMed |
| Regulation of OATP1B1 Function by Tyrosine Kinase-mediated Phosphorylation. | Clin Cancer Res | 2021 | 33664059 | PubTator, text mining | PubMed |
| Relationship of hemoglobin level and plasma coproporphyrin-I concentrations as an endogenous probe for phenotyping OATP1B. | Clin Transl Sci | 2021 | 33650309 | PubTator, text mining | PubMed |
| Low risk of the TMPRSS2 inhibitor camostat mesylate and its metabolite GBPA to act as perpetrators of drug-drug interactions. | Chem Biol Interact | 2021 | 33647240 | PubTator, text mining | PubMed |
| Latent trait modeling of tau neuropathology in progressive supranuclear palsy. | Acta Neuropathol | 2021 | 33635380 | PubTator, text mining | PubMed |
| Differential Associations of SLCO Transporters with Prostate Cancer Aggressiveness between African Americans and European Americans. | Cancer Epidemiol Biomarkers Prev | 2021 | 33619025 | PubTator, text mining | PubMed |
| Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection. | J Clin Transl Hepatol | 2021 | 33604263 | PubTator, text mining | PubMed |
| OATP1B3 Expression in Hepatocellular Carcinoma Correlates with Intralesional Gd-EOB-DTPA Uptake and Signal Intensity on Gd-EOB-DTPA-Enhanced MRI. | Cancer Manag Res | 2021 | 33603462 | PubTator, text mining | PubMed |
| Treating the patient and not just the cancer: therapeutic burden in prostate cancer. | Prostate Cancer Prostatic Dis | 2021 | 33603236 | PubTator, text mining | PubMed |
| Hepatic organic anion transporting polypeptides mediate disposition of milk thistle flavonolignans and pharmacokinetic silymarin-drug interactions. | Phytother Res | 2021 | 33587330 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6579/papers?page=44